Anna C. Beck

1.9k total citations
72 papers, 705 citations indexed

About

Anna C. Beck is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Clinical Psychology. According to data from OpenAlex, Anna C. Beck has authored 72 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 21 papers in Public Health, Environmental and Occupational Health and 10 papers in Clinical Psychology. Recurrent topics in Anna C. Beck's work include Palliative Care and End-of-Life Issues (19 papers), Breast Cancer Treatment Studies (7 papers) and Frailty in Older Adults (6 papers). Anna C. Beck is often cited by papers focused on Palliative Care and End-of-Life Issues (19 papers), Breast Cancer Treatment Studies (7 papers) and Frailty in Older Adults (6 papers). Anna C. Beck collaborates with scholars based in United States, Japan and United Kingdom. Anna C. Beck's co-authors include Gerald Rothstein, Ronald J. Weigel, Eric L. Garland, Michael J. Mosier, Richard L. Gamelli, Lee Ellington, Maija Reblin, Shelley White, Kristin G. Cloyes and Jordan P. McPherson and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Nature Nanotechnology.

In The Last Decade

Anna C. Beck

69 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna C. Beck United States 15 208 126 99 92 92 72 705
Sarah E. Daugherty United States 19 186 0.9× 179 1.4× 143 1.4× 189 2.1× 175 1.9× 33 1.4k
Damila Cristina Trufelli Brazil 12 230 1.1× 39 0.3× 119 1.2× 189 2.1× 79 0.9× 27 781
Carles Forné Spain 13 145 0.7× 34 0.3× 147 1.5× 62 0.7× 134 1.5× 41 712
Krista Payne United States 14 158 0.8× 74 0.6× 49 0.5× 63 0.7× 40 0.4× 21 893
Yiduo Zhang United States 15 164 0.8× 56 0.4× 197 2.0× 97 1.1× 137 1.5× 22 1.1k
Beatriz Castelo Spain 17 368 1.8× 36 0.3× 84 0.8× 82 0.9× 110 1.2× 50 682
Miep A. van der Drift Netherlands 14 279 1.3× 145 1.2× 59 0.6× 119 1.3× 317 3.4× 22 909
Pierluigi Russo Italy 20 149 0.7× 52 0.4× 73 0.7× 95 1.0× 71 0.8× 89 1.2k
Su‐Jin Koh South Korea 16 227 1.1× 82 0.7× 254 2.6× 121 1.3× 114 1.2× 88 745
Yafang Huang China 16 230 1.1× 38 0.3× 48 0.5× 90 1.0× 126 1.4× 35 750

Countries citing papers authored by Anna C. Beck

Since Specialization
Citations

This map shows the geographic impact of Anna C. Beck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna C. Beck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna C. Beck more than expected).

Fields of papers citing papers by Anna C. Beck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna C. Beck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna C. Beck. The network helps show where Anna C. Beck may publish in the future.

Co-authorship network of co-authors of Anna C. Beck

This figure shows the co-authorship network connecting the top 25 collaborators of Anna C. Beck. A scholar is included among the top collaborators of Anna C. Beck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna C. Beck. Anna C. Beck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rudra, Arnab, Akash Gupta, Amy Deik, et al.. (2025). Degradable cyclic amino alcohol ionizable lipids as vectors for potent influenza mRNA vaccines. Nature Nanotechnology. 20(12). 1831–1842. 1 indexed citations
2.
Vaklavas, Christos, Cindy Matsen, Zhengtao Chu, et al.. (2024). TOWARDS Study: Patient-Derived Xenograft Engraftment Predicts Poor Survival in Patients With Newly Diagnosed Triple-Negative Breast Cancer. JCO Precision Oncology. 8(8). e2300724–e2300724. 3 indexed citations
3.
McPherson, Jordan P., et al.. (2024). Patient and Caregiver Perceptions of an Interface Design to Communicate Artificial Intelligence–Based Prognosis for Patients With Advanced Solid Tumors. JCO Clinical Cancer Informatics. 8(8). e2300187–e2300187. 2 indexed citations
4.
Beck, Anna C. & Ingrid M. Lizarraga. (2024). Long-Term Burden of Breast Cancer-Related Lymphedema. Current Breast Cancer Reports. 16(2). 251–259. 3 indexed citations
5.
Beck, Anna C., George Plitas, Varadan Sevilimedu, et al.. (2023). Does Non-Classic Lobular Carcinoma In Situ at the Lumpectomy Margin Increase Local Recurrence?. Annals of Surgical Oncology. 30(10). 6061–6069. 1 indexed citations
6.
Fuller, Timothy, et al.. (2022). Undue Influence versus Relational Autonomy in Clinical Decision Making #439. Journal of Palliative Medicine. 25(6). 996–997. 2 indexed citations
7.
McPherson, Jordan P., et al.. (2022). Development of a Machine Learning Model Using Limited Features to Predict 6-Month Mortality at Treatment Decision Points for Patients With Advanced Solid Tumors. JCO Clinical Cancer Informatics. 6(6). e2100163–e2100163. 7 indexed citations
8.
Reblin, Maija, Eli Iacob, Djin Tay, et al.. (2022). Family Caregiver Reports of Their Own and Patient Symptoms in Cancer Home Hospice Approaching End-of-Life. American Journal of Hospice and Palliative Medicine®. 40(5). 508–516. 2 indexed citations
9.
Beck, Anna C., et al.. (2021). AP-2α–Mediated Activation of E2F and EZH2 Drives Melanoma Metastasis. Cancer Research. 81(17). 4455–4470. 26 indexed citations
10.
Bleicher, Josh, et al.. (2021). Preoperative Advance Care Planning for Older Adults Undergoing Major Abdominal Surgery. American Journal of Hospice and Palliative Medicine®. 39(4). 406–412. 9 indexed citations
11.
Beck, Anna C., Edward H. Cho, Lily Paemka, et al.. (2021). AP-2α Regulates S-Phase and Is a Marker for Sensitivity to PI3K Inhibitor Buparlisib in Colon Cancer. Molecular Cancer Research. 19(7). 1156–1167. 17 indexed citations
12.
Coletta, Adriana M., Mary C. Playdon, Kelly Glazer Baron, et al.. (2021). The association between time-of-day of habitual exercise training and changes in relevant cancer health outcomes among cancer survivors. PLoS ONE. 16(10). e0258135–e0258135. 2 indexed citations
13.
14.
Kelley, Sarah A., Anna C. Beck, Ronald J. Weigel, et al.. (2021). Influence of endocrine multidisciplinary tumor board on patient management and treatment decision making. The American Journal of Surgery. 223(1). 76–80. 4 indexed citations
16.
Beck, Anna C., Nicholas Borcherding, Tiandao Li, et al.. (2019). A TFAP2C Gene Signature Is Predictive of Outcome in HER2-Positive Breast Cancer. Molecular Cancer Research. 18(1). 46–56. 13 indexed citations
17.
Cloyes, Kristin G., et al.. (2018). We're the Eyes and the Ears, but We Don't Have a Voice. Journal of Hospice and Palliative Nursing. 20(1). 47–54. 24 indexed citations
18.
Goffredo, Paolo, Alan F. Utria, Anna C. Beck, et al.. (2018). The Prognostic Impact of KRAS Mutation in Patients Having Curative Resection of Synchronous Colorectal Liver Metastases. Journal of Gastrointestinal Surgery. 23(10). 1957–1963. 25 indexed citations
19.
Beck, Anna C., Paolo Goffredo, Imran Hassan, et al.. (2018). Risk factors for 30-day readmission after adrenalectomy. Surgery. 164(4). 766–773. 12 indexed citations
20.
Beck, Anna C., et al.. (2015). Predicting Mechanical Ventilation and Mortality. Journal of Burn Care & Research. 37(1). e47–e55. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026